diabetes

Eli Lilly’s Generic Insulin Hits Market at Half the Price of Branded Counterpart
Eli Lilly’s Generic Insulin Hits Market at Half the Price of Branded Counterpart
BioSpace
Eli Lilly
drug pricing
generics
insulin
diabetes
Lispro
KwikPens
Flag link:
Highlights: 2019 Cardiometabolic Health Congress West
Highlights: 2019 Cardiometabolic Health Congress West
CP Wire
diabetes
heart disease
cardiometabolic health
heart failure
cardiovascular disease
Flag link:
Highlights: 2019 Cardiometabolic Health Congress West
diabetes
heart disease
cardiometabolic health
heart failure
Flag link:
3 Top Diabetes Stocks to Watch in May
3 Top Diabetes Stocks to Watch in May
Motley Fool
diabetes
AstraZeneca
Eli Lilly
Medtronic
Flag link:
Interchangeable Insulins: FDA Holds Public Meeting
Interchangeable Insulins: FDA Holds Public Meeting
RAPS.org
diabetes
insulin
biosimilars
FDA
biosimilar insulin
Flag link:
Novo Nordisk Trots Along Waiting for Its Next-Generation Oral Drug
Novo Nordisk Trots Along Waiting for Its Next-Generation Oral Drug
Motley Fool
Novo Nordisk
earnings
diabetes
oral semaglutide
FDA
Flag link:
Researchers warn about gangrene cases in patients on SGLT2 diabetes drugs
Researchers warn about gangrene cases in patients on SGLT2 diabetes drugs
Fierce Pharma
gangrene
diabetes
JNJ
Invokana
AstraZeneca
Farxiga
Eli Lilly
Boehringer Ingelheim
Jardiance
Flag link:
Oramed spearheading human oral insulin trials in 37 US centers
Oramed spearheading human oral insulin trials in 37 US centers
CP Wire
Oramed
insulin
oral insulin
diabetes
type 2 diabetes
clinical trials
Flag link:
Oramed spearheading human oral insulin trials in 37 US centers
Oramed
insulin
type 2 diabetes
diabetes
clinical trials
oral insulin
Flag link:
Why Diabetes-Disruptor Insulet Is Skyrocketing 10% Today
Why Diabetes-Disruptor Insulet Is Skyrocketing 10% Today
Motley Fool
Insulet
diabetes
insulin pumps
devices
Flag link:
Express Scripts excludes Lilly's new low cost insulin generic
Express Scripts excludes Lilly's new low cost insulin generic
BioCentury
Express Scripts
Eli Lilly
generics
diabetes
insulin
PBMs
Humalog
Flag link:
Sanofi's Eloctate, a Bioverativ buyout centerpiece, suffers on Roche's Hemlibra launch
Sanofi's Eloctate, a Bioverativ buyout centerpiece, suffers on Roche's Hemlibra launch
Fierce Pharma
Sanofi
Bioverativ
M&A
diabetes
Eloctate
Roche
Hemlibra
Flag link:
Drugs could mimic gut bacteria benefits to treat diabetes
Drugs could mimic gut bacteria benefits to treat diabetes
Pharmaforum
diabetes
drug development
microbiome
gut bacteria
Flag link:
3 Top Diabetes Stocks to Watch in April
3 Top Diabetes Stocks to Watch in April
Motley Fool
diabetes
Medtronic
devices
Tandem Diabetes Care
DexCom
blood glucose monitoring
insulin pumps
Flag link:
Outracing 2 giant rivals, J&J touts promising PhIII Invokana data as a game-changer for kidney disease risks
Outracing 2 giant rivals, J&J touts promising PhIII Invokana data as a game-changer for kidney disease risks
Endpoints
JNJ
Invokana
diabetes
kidney disease
Flag link:
Trial sets up 2020 filing for Poxel’s novel diabetes drug
Trial sets up 2020 filing for Poxel’s novel diabetes drug
Pharmaforum
Poxel
Japan
diabetes
type 2 diabetes
clinical trials
imeglimin
Flag link:
Before House hearing, Sanofi cuts insulin prices for some patients
Before House hearing, Sanofi cuts insulin prices for some patients
Stat
Sanofi
insulin
diabetes
drug pricing
Flag link:
Sanofi plans sales layoffs—again—in primary care, diabetes
Sanofi plans sales layoffs—again—in primary care, diabetes
Fierce Pharma
Sanofi
layoffs
primary care
diabetes
drug reps
Flag link:
Cigna’s Express Scripts PBM To Cap Insulin Costs Amid Drug Price Scrutiny
Cigna’s Express Scripts PBM To Cap Insulin Costs Amid Drug Price Scrutiny
Forbes
Express Scripts
PBMs
insulin
diabetes
drug pricing
Flag link:
Better Diabetes Care: Healthcare Startups Say They’ll Get Paid When Patients Get Better
Better Diabetes Care: Healthcare Startups Say They’ll Get Paid When Patients Get Better
Forbes
diabetes
value-based care
patients
startups
Flag link:

Pages